Metformin in women with PCOS, cons. - Wikidata - wikimedia - TriplyDB

Metformin in women with PCOS, cons.

Metformin in women with PCOS, cons.

http://www.wikidata.org/entity/Q38245312

about

Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials.Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.Metformin: New Preparations and Nonglycemic Benefits.

P2860

Q34557177-5F67EC3F-247E-407C-B3FE-56A9AF8EEB67 Q39026021-087A96A2-53AC-40C9-8A43-DD4A12C68969 Q39100209-15C6D0DA-05BF-4C32-A481-F4BABC903E26

P2860

Metformin in women with PCOS, cons.

http://www.wikidata.org/entity/Q38245312

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Metformin in women with PCOS, cons.

@en

type

label

Metformin in women with PCOS, cons.

@en

prefLabel

Metformin in women with PCOS, cons.

@en

P1433

Q38245312-F96A540B-3631-4086-964A-B8410ADD8161

P1476

Q38245312-A09B7F65-BECC-47CB-B24B-4F616BDB1D90

P2093

Q38245312-35BE82C1-7374-4693-B3F8-B0C6EB399B82

P2860

Q38245312-06EDC239-D199-45C7-BDD8-3A7F15F97F53

Q38245312-1C7D63B3-2794-464C-865C-0BEB77BBCECC

Q38245312-298C7737-A6A0-4422-8A7D-17945A67F022

Q38245312-2A8F93AC-7419-4F07-8878-C15382C51BE4

Q38245312-37642A3F-5FE4-41DE-8045-5C2472BF4F09

Q38245312-3DC10581-6DB3-4F99-9882-3C2ADE1F865F

Q38245312-3DD67295-C416-40C2-BB4E-F4C667E358BB

Q38245312-4F154A4E-D616-4D1A-98A7-E8CDD6520EDC

Q38245312-5353BF86-46EB-4FCA-A109-73B68A02EF40

Q38245312-56454E32-3467-4F17-8BB9-00491A530EA1

P2888

Q38245312-19636C33-037F-442F-8FDE-DA26F6BD5D11

P304

Q38245312-1E27E790-6C1F-42A4-AD0D-6F9732BE90AE

P31

Q38245312-49B31F82-4F09-430D-929A-96290F35440A

P356

Q38245312-360423AC-76E3-4236-914D-CAFE9CC137CE

P433

Q38245312-7C17FDC4-73C3-4193-BD9C-AA106BF6E612

P478

Q38245312-86CEEA88-CB1F-471E-A641-02FF814147E5

P50

Q38245312-0CEB73DF-E2BB-4AEA-BAB0-FCE841D0B38B

P577

Q38245312-91DD4CAC-3805-455D-8D3C-D487AE9A1A67

P698

Q38245312-C6E831D1-7D7A-4E75-8F13-546223A9368C

P921

Q38245312-CC2680EA-0A0F-44B3-B854-D7AF6F072847

P356

S12020-014-0394-8

P1433

P1476

Metformin in women with PCOS, cons

@en

P2093

Marie L Misso

http://www.w3.org/2001/XMLSchema#string

P2860

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis.

Endometrium in PCOS: Implantation and predisposition to endocrine CA.

P2888

s12020-014-0394-8

P304

428-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12020-014-0394-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Helena J. Teede

P577

2014-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25178647

http://www.w3.org/2001/XMLSchema#string

P921